These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23819873)

  • 41. Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus.
    Winge K; Nielsen KK; Stimpel H; Lokkegaard A; Jensen SR; Werdelin L
    Mov Disord; 2007 Jan; 22(2):220-5. PubMed ID: 17133504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urgency assessment in the evaluation of overactive bladder (OAB).
    Starkman JS; Dmochowski RR
    Neurourol Urodyn; 2008; 27(1):13-21. PubMed ID: 17671973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse.
    Foster RT; Barber MD; Parasio MF; Walters MD; Weidner AC; Amundsen CL
    Am J Obstet Gynecol; 2007 Jul; 197(1):82.e1-4. PubMed ID: 17618768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [French translation and linguistic validation of the questionnaire Bladder Cancer Index (BCI)].
    Gaunez N; Larré S; Pirès C; Doré B; Wei J; Pfister C; Irani J
    Prog Urol; 2010 May; 22(6):350-3. PubMed ID: 22541905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptoms.
    Chapple CR; Drake MJ; Van Kerrebroeck P; Cardozo L; Drogendijk T; Klaver M; Van Charldorp K; Hakimi Z; Compion G
    BJU Int; 2014 May; 113(5):696-703. PubMed ID: 24712917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is the prevalence of overactive bladder overestimated? A population-based study in Finland.
    Tikkinen KA; Tammela TL; Rissanen AM; Valpas A; Huhtala H; Auvinen A
    PLoS One; 2007 Feb; 2(2):e195. PubMed ID: 17332843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Animal models in overactive bladder research.
    Parsons BA; Drake MJ
    Handb Exp Pharmacol; 2011; (202):15-43. PubMed ID: 21290220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Female urinary incontinence - urodynamics: yes or no?
    Renganathan A; Duckett J; Nayak K
    J Obstet Gynaecol; 2009 Aug; 29(6):473-9. PubMed ID: 19697192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.
    Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P
    Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overactive bladder: diagnosis and management.
    Robinson D; Cardozo L
    Maturitas; 2012 Feb; 71(2):188-93. PubMed ID: 22197347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
    DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
    Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical efficacy and tolerability of gosha-jinki-gan, Japanese traditional herbal medicine, in females with overactive bladder.
    Kajiwara M; Mutaguchi K
    Hinyokika Kiyo; 2008 Feb; 54(2):95-9. PubMed ID: 18323165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Finger taps and constipation are closely related to symptoms of overactive bladder in male patients with Parkinson's disease.
    Tsujimura A; Yamamoto Y; Sakoda S; Okuda H; Yamamoto K; Fukuhara S; Yoshioka I; Kiuchi H; Takao T; Miyagawa Y; Nonomura N
    Int J Urol; 2014 Jan; 21(1):69-73. PubMed ID: 23659545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bladder sensation measures and overactive bladder.
    Rapp DE; Neil NJ; Govier FE; Kobashi KC
    J Urol; 2009 Sep; 182(3):1050-4. PubMed ID: 19616792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Impact of urinary incontinence and overactive bladder syndrome on health-related quality of life of working middle-aged patients and institutionalized elderly patients].
    Martínez Agulló E; Ruíz Cerdá JL; Gómez Pérez L; Rebollo P; Pérez M; Chaves J
    Actas Urol Esp; 2010 Mar; 34(3):242-50. PubMed ID: 20416241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response to Linguistic and psychometric validation of the Malaysian version of Diabetes Quality of Life-Brief Clinical Inventory (DQoL-BCI): Methodological issues to avoid misinterpretation.
    Neoh CF; Samah S; Wong YY; Hassali MA; Shafie AA; Lim SM; Ramasamy K; Mat Nasir N; Han YW; Burroughs T
    Res Social Adm Pharm; 2017; 13(4):884. PubMed ID: 28259586
    [No Abstract]   [Full Text] [Related]  

  • 58. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD; Liao CH; Chen YC; Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Chapple C; Herschorn S; Abrams P; Sun F; Brodsky M; Guan Z
    Eur Urol; 2009 Sep; 56(3):534-41. PubMed ID: 19070418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: an open-label, multicenter, prospective study.
    Chung JH; Lee JY; Kang DH; Ha US; Lee SH; Ham WS; Cho KS; Han JH; Park J; Yoo TK; Lee SW
    Neurourol Urodyn; 2012 Sep; 31(7):1175-80. PubMed ID: 22674356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.